Ligand validation:6X9D

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6X9D_NAD_B_2005	85%	6%	0.094	0.959	3.43	1.64	15	5	2	0	100%	1
6X9D_NAD_A_2005	75%	6%	0.094	0.926	3.54	1.67	16	6	2	0	100%	1
9E0E_NAD_B_1312	98%	16%	0.052	0.978	2.11	1.57	8	5	2	0	100%	1
9DL9_NAD_B_2011	98%	18%	0.055	0.976	2.03	1.53	7	3	2	0	100%	1
9E0A_NAD_B_1306	98%	16%	0.054	0.975	2.14	1.59	7	5	2	0	100%	1
9E0B_NAD_B_1312	98%	15%	0.054	0.975	2.13	1.63	8	4	2	0	100%	1
9E0C_NAD_B_1311	97%	16%	0.056	0.973	2.12	1.58	8	5	2	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.